| Year |
Citation |
Score |
| 2007 |
Schottenbauer MA, Hommer D, Weingartner H. Memory deficits among alcoholics: performance on a selective reminding task. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 14: 505-16. PMID 17828626 DOI: 10.1080/13825580600681305 |
0.353 |
|
| 1997 |
Martinez R, Molchan SE, Lawlor BA, Thompson K, Martinson H, Latham G, Weingartner H, Sunderland T. Minimal effects of dextroamphetamine on scopolamine-induced cognitive impairments in humans. Biological Psychiatry. 41: 50-7. PMID 8988795 DOI: 10.1016/0006-3223(95)00674-5 |
0.44 |
|
| 1996 |
Danion JM, Weingartner H, Singer L. Is cognitive psychopathology plausible? Illustrations from memory research. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 41: S5-13. PMID 8884046 DOI: 10.1177/070674379604100702 |
0.446 |
|
| 1996 |
Weingartner HJ, Andreason PJ, Hommer DW, Sirocco KY, Rio DE, Ruttimann UE, Rawlings RR, Eckardt MJ. Monitoring the source of memory in detoxified alcoholics. Biological Psychiatry. 40: 43-53. PMID 8780854 DOI: 10.1016/0006-3223(95)00290-1 |
0.305 |
|
| 1996 |
Grasing K, Murphy MG, Lin J, Swigar M, Freedholm D, Clarke L, Zhang J, Wolkowitz OM, Weingartner H, Putnam K, Seibold JR. Human pharmacokinetics and tolerability of L-365,260, a novel cholecystokinin-B antagonist. Journal of Clinical Pharmacology. 36: 292-300. PMID 8728342 DOI: 10.1002/J.1552-4604.1996.Tb04204.X |
0.31 |
|
| 1996 |
Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 14: 301-7. PMID 8703299 DOI: 10.1016/0893-133X(95)00137-3 |
0.416 |
|
| 1996 |
Sunderland T, Molchan S, Bahro M, Dukoff R, Little J, Vitiello B, Martinez R, Weingartner H. 186 Pharmacologic challenges in Alzheimer's disease and normal controls: Cognitive modelling in humans Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80188-6 |
0.332 |
|
| 1995 |
Curran HV, Barrow S, Weingartner H, Lader M, Bernik M. Encoding, remembering and awareness in lorazepam-induced amnesia. Psychopharmacology. 122: 187-93. PMID 8848535 DOI: 10.1007/Bf02246094 |
0.347 |
|
| 1995 |
Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H. Antidepressant and cognition-enhancing effects of DHEA in major depression. Annals of the New York Academy of Sciences. 774: 337-9. PMID 8597481 DOI: 10.1111/J.1749-6632.1995.Tb17403.X-I1 |
0.329 |
|
| 1995 |
Weingartner HJ, Sirocco K, Rawlings R, Joyce E, Hommer D. Dissociations in the expression of the sedative effects of triazolam. Psychopharmacology. 119: 27-33. PMID 7675946 DOI: 10.1007/Bf02246050 |
0.302 |
|
| 1995 |
Martin PR, Adinoff B, Lane E, Stapleton JM, Bone GA, Weingartner H, Linnoila M, Eckardt MJ. Fluvoxamine treatment of alcoholic amnestic disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 5: 27-33. PMID 7542052 DOI: 10.1016/0924-977X(94)00129-Y |
0.383 |
|
| 1995 |
Fleishaker JC, Garzone PD, Chambers JH, Sirocco K, Weingartner H. Comparison of the spectrum of cognitive effects of alprazolam and adinazolam after single doses in healthy subjects. Psychopharmacology. 120: 169-76. PMID 7480549 DOI: 10.1007/BF02246190 |
0.436 |
|
| 1994 |
Reus VI, Wolkowitz OM, Roberts E, Chan T, Turetsky N, Manfredi F, Weingartner H. Dehydroepiandrosterone (DHEA) and memory in depressed patients Biological Psychiatry. 35: 642. DOI: 10.1016/0006-3223(94)90755-2 |
0.435 |
|
| 1994 |
Weingartner H, Sirocco K, Eckardt M, Hommer D, Johnson DN. Cognitive control functions in memory-impaired subjects: A neuropharmacological model Biological Psychiatry. 35: 640. DOI: 10.1016/0006-3223(94)90750-1 |
0.433 |
|
| 1993 |
Danion JM, Weingartner H, File SE, Jaffard R, Sunderland T, Tulving E, Warburton DM. Pharmacology of human memory and cognition: illustrations from the effects of benzodiazepines and cholinergic drugs. Journal of Psychopharmacology (Oxford, England). 7: 371-7. PMID 22291001 DOI: 10.1177/026988119300700409 |
0.45 |
|
| 1993 |
Weingartner HJ, Joyce EM, Sirocco KY, Adams CM, Eckardt MJ, George T, Lister RG. Specific memory and sedative effects of the benzodiazepine triazolam. Journal of Psychopharmacology (Oxford, England). 7: 305-15. PMID 22290993 DOI: 10.1177/026988119300700401 |
0.347 |
|
| 1993 |
Wolkowitz OM, Weingartner H, Rubinow DR, Jimerson D, Kling M, Berretini W, Thompson K, Breier A, Doran A, Reus VI. Steroid modulation of human memory: biochemical correlates. Biological Psychiatry. 33: 744-6. PMID 8102553 DOI: 10.1016/0006-3223(93)90125-W |
0.35 |
|
| 1993 |
Hommer D, Weingartner H, Breier A. Dissociation of benzodiazepine-induced amnesia from sedation by flumazenil pretreatment. Psychopharmacology. 112: 455-60. PMID 7871057 DOI: 10.1007/Bf02244894 |
0.453 |
|
| 1993 |
Weingartner H, Eckardt M, Grafman J, Molchan S, Putnam K, Rawlings R, Sunderland T. The Effects of Repetition on Memory Performance in Cognitively Impaired Patients Neuropsychology. 7: 385-395. DOI: 10.1037/0894-4105.7.3.385 |
0.447 |
|
| 1992 |
Molchan SE, Mellow AM, Hill JL, Weingartner H, Martinez R, Vitiello B, Sunderland T. The effects of thyrotropin-releasing hormone and scopolamine in Alzheimer's disease and normal volunteers. Journal of Psychopharmacology (Oxford, England). 6: 489-500. PMID 22291397 DOI: 10.1177/026988119200600404 |
0.424 |
|
| 1992 |
Pappas BA, Sunderland T, Weingartner HM, Vitiello B, Martinson H, Putnam K. Alzheimer's disease and feeling-of-knowing for knowledge and episodic memory. Journal of Gerontology. 47: P159-64. PMID 1573198 |
0.308 |
|
| 1992 |
Weingartner HJ, Hommer D, Lister RG, Thompson K, Wolkowitz O. Selective effects of triazolam on memory. Psychopharmacology. 106: 341-5. PMID 1570380 DOI: 10.1007/Bf02245415 |
0.348 |
|
| 1992 |
Molchan SE, Martinez RA, Hill JL, Weingartner HJ, Thompson K, Vitiello B, Sunderland T. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model. Brain Research. Brain Research Reviews. 17: 215-26. PMID 1467811 DOI: 10.1016/0165-0173(92)90017-G |
0.362 |
|
| 1990 |
Wolkowitz OM, Reus VI, Weingartner H, Thompson K, Breier A, Doran A, Rubinow D, Pickar D. Cognitive effects of corticosteroids. The American Journal of Psychiatry. 147: 1297-303. PMID 2399996 DOI: 10.1176/ajp.147.10.1297 |
0.301 |
|
| 1990 |
Grafman J, Weingartner H, Newhouse PA, Thompson K, Lalonde F, Litvan I, Molchan S, Sunderland T. Implicit learning in patients with Alzheimer's disease. Pharmacopsychiatry. 23: 94-101. PMID 2339182 DOI: 10.1055/S-2007-1014490 |
0.353 |
|
| 1990 |
Grafman J, Weingartner H, Lawlor B, Mellow AM, Thompsen-Putnam K, Sunderland T. Automatic memory processes in patients with dementia-Alzheimer's type (DAT). Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 26: 361-71. PMID 2249437 DOI: 10.1016/S0010-9452(13)80086-X |
0.396 |
|
| 1990 |
Molchan SE, Mellow AM, Lawlor BA, Weingartner HJ, Cohen RM, Cohen MR, Sunderland T. TRH attenuates scopolamine-induced memory impairment in humans. Psychopharmacology. 100: 84-9. PMID 2104988 DOI: 10.1007/BF02245795 |
0.333 |
|
| 1989 |
Sunderland T, Weingartner H, Cohen RM, Tariot PN, Newhouse PA, Thompson KE, Lawlor BA, Mueller EA. Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controls. Psychopharmacology. 99: 129-33. PMID 2506598 DOI: 10.1007/BF00634466 |
0.344 |
|
| 1988 |
Newhouse PA, Sunderland T, Tariot PN, Weingartner H, Thompson K, Mellow AM, Cohen RM, Murphy DL. The effects of acute scopolamine in geriatric depression. Archives of General Psychiatry. 45: 906-12. PMID 3048225 DOI: 10.1001/Archpsyc.1988.01800340028004 |
0.405 |
|
| 1988 |
Tariot PN, Cohen RM, Welkowitz JA, Sunderland T, Newhouse PA, Murphy DL, Weingartner H. Multiple-dose arecoline infusions in Alzheimer's disease. Archives of General Psychiatry. 45: 901-5. PMID 3048224 DOI: 10.1001/Archpsyc.1988.01800340023003 |
0.414 |
|
| 1987 |
Wolkowitz OM, Weingartner H, Thompson K, Pickar D, Paul SM, Hommer DW. Diazepam-induced amnesia: a neuropharmacological model of an "organic amnestic syndrome". The American Journal of Psychiatry. 144: 25-9. PMID 3799835 DOI: 10.1176/Ajp.144.1.25 |
0.432 |
|
| 1987 |
Sunderland T, Tariot PN, Cohen RM, Weingartner H, Mueller EA, Murphy DL. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study. Archives of General Psychiatry. 44: 418-26. PMID 3579494 DOI: 10.1097/00002093-198701040-00036 |
0.377 |
|
| 1987 |
Tariot PN, Sunderland T, Weingartner H, Murphy DL, Welkowitz JA, Thompson K, Cohen RM. Cognitive effects of L-deprenyl in Alzheimer's disease. Psychopharmacology. 91: 489-95. PMID 3108930 DOI: 10.1007/Bf00216016 |
0.351 |
|
| 1987 |
Tariot PN, Cohen RM, Sunderland T, Newhouse PA, Yount D, Mellow AM, Weingartner H, Mueller EA, Murphy DL. L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition. Archives of General Psychiatry. 44: 427-33. PMID 3107514 DOI: 10.1001/Archpsyc.1987.01800170041007 |
0.32 |
|
| 1987 |
Roy-Byrne PP, Uhde TW, Holcomb H, Thompson K, King AK, Weingartner H. Effects of diazepam on cognitive processes in normal subjects. Psychopharmacology. 91: 30-3. PMID 3103156 DOI: 10.1007/Bf00690922 |
0.32 |
|
| 1987 |
Tariot P, Sunderland T, Weingartner H, Murphy D, Cohen, Cohen R. Naloxone and Alzheimerʼs disease: cognitive and behavioral effects of a range of doses Alzheimer Disease & Associated Disorders. 1: 270-271. DOI: 10.1097/00002093-198701040-00034 |
0.34 |
|
| 1986 |
Roy-Byrne PP, Weingartner H, Bierer LM, Thompson K, Post RM. Effortful and automatic cognitive processes in depression. Archives of General Psychiatry. 43: 265-7. PMID 3954546 DOI: 10.1001/archpsyc.1986.01800030083008 |
0.354 |
|
| 1986 |
Grafman J, Vance SC, Weingartner H, Salazar AM, Amin D. The effects of lateralized frontal lesions on mood regulation. Brain : a Journal of Neurology. 109: 1127-48. PMID 3790971 DOI: 10.1093/brain/109.6.1127 |
0.325 |
|
| 1986 |
Tariot PN, Weingartner H. A psychobiologic analysis of cognitive failures. Structure and mechanisms. Archives of General Psychiatry. 43: 1183-8. PMID 3778113 DOI: 10.1001/archpsyc.1986.01800120069014 |
0.433 |
|
| 1986 |
Strupp BJ, Weingartner H, Kaye W, Gwirtsman H. Cognitive processing in anorexia nervosa. A disturbance in automatic information processing. Neuropsychobiology. 15: 89-94. PMID 3762904 DOI: 10.1159/000118248 |
0.368 |
|
| 1986 |
Tariot PN, Sunderland T, Weingartner H, Murphy DL, Cohen MR, Cohen RM. Naloxone and Alzheimer's disease. Cognitive and behavioral effects of a range of doses. Archives of General Psychiatry. 43: 727-32. PMID 3729666 DOI: 10.1001/Archpsyc.1986.01800080013002 |
0.411 |
|
| 1986 |
Grafman J, Salazar AM, Weingartner H, Amin D. Face memory and discrimination: an analysis of the persistent effects of penetrating brain wounds. The International Journal of Neuroscience. 29: 125-39. PMID 3699997 DOI: 10.3109/00207458608985643 |
0.357 |
|
| 1986 |
Sunderland T, Tariot PN, Weingartner H, Murphy DL, Newhouse PA, Mueller EA, Cohen RM. Pharmacologic modelling of Alzheimer's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 10: 599-610. PMID 3541054 DOI: 10.1016/0278-5846(86)90030-8 |
0.394 |
|
| 1986 |
Tariot PN, Sunderland T, Murphy DL, Cohen MR, Welkowitz JA, Weingartner H, Newhouse PA, Cohen RM. Design and interpretation of opiate antagonist trials in dementia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 10: 611-26. PMID 3025928 DOI: 10.1016/0278-5846(86)90031-X |
0.326 |
|
| 1985 |
Grafman J, Salazar AM, Weingartner H, Vance SC, Ludlow C. Isolated impairment of memory following a penetrating lesion of the fornix cerebri. Archives of Neurology. 42: 1162-8. PMID 4062614 DOI: 10.1001/archneur.1985.04060110044014 |
0.393 |
|
| 1985 |
Silberman EK, Weingartner H, Targum SD, Byrnes S. Cognitive functioning in biological subtypes of depression. Biological Psychiatry. 20: 654-61. PMID 3995112 DOI: 10.1016/0006-3223(85)90100-3 |
0.411 |
|
| 1985 |
Sunderland T, Tariot P, Murphy DL, Weingartner H, Mueller EA, Cohen RM. Scopolamine challenges in Alzheimer's disease. Psychopharmacology. 87: 247-9. PMID 3931154 DOI: 10.1007/Bf00431817 |
0.367 |
|
| 1985 |
Weingartner H, Rudorfer MV, Linnoila M. Cognitive effects of lithium treatment in normal volunteers. Psychopharmacology. 86: 472-4. PMID 3929320 DOI: 10.1007/Bf00427911 |
0.457 |
|
| 1985 |
Hommer DW, Pickar D, Crawley JN, Weingartner H, Paul SM. The effects of cholecystokinin-like peptides in schizophrenics and normal human subjects. Annals of the New York Academy of Sciences. 448: 542-52. PMID 3896099 DOI: 10.1111/J.1749-6632.1985.Tb29947.X |
0.37 |
|
| 1985 |
Silberman EK, Putnam FW, Weingartner H, Braun BG, Post RM. Dissociative states in multiple personality disorder: a quantitative study. Psychiatry Research. 15: 253-60. PMID 3865243 DOI: 10.1016/0165-1781(85)90062-9 |
0.378 |
|
| 1985 |
Tariot P, Sunderland T, Murphy D, Cohen R, Weingartner H, Makohon R. Alzheimer's disease. How memory fails: a theoretical model. Geriatric Nursing (New York, N.Y.). 6: 144-7. PMID 3845902 DOI: 10.1016/S0197-4572(85)80028-8 |
0.356 |
|
| 1985 |
Weingartner H. Models of memory dysfunctions. Annals of the New York Academy of Sciences. 444: 359-69. PMID 2990294 DOI: 10.1111/J.1749-6632.1985.Tb37601.X |
0.365 |
|
| 1985 |
Strauss ME, Weingartner H, Thompson K. Remembering words and how often they occurred in memory-impaired patients. Memory & Cognition. 13: 507-10. PMID 2937990 DOI: 10.3758/BF03198321 |
0.457 |
|
| 1985 |
Wolkowitz OM, Tinklenberg JR, Weingartner H. A psychopharmacological perspective of cognitive functions. II. Specific pharmacologic agents. Neuropsychobiology. 14: 133-56. PMID 2421196 DOI: 10.1159/000118219 |
0.396 |
|
| 1984 |
Ross RJ, Smallberg S, Weingartner H. The effects of desmethylimipramine on cognitive function in healthy subjects. Psychiatry Research. 12: 89-97. PMID 6589660 DOI: 10.1016/0165-1781(84)90141-0 |
0.426 |
|
| 1984 |
Weingartner H, Burns S, Diebel R, LeWitt PA. Cognitive impairments in Parkinson's disease: distinguishing between effort-demanding and automatic cognitive processes. Psychiatry Research. 11: 223-35. PMID 6587415 DOI: 10.1016/0165-1781(84)90071-4 |
0.388 |
|
| 1984 |
Martin PR, Ebert MH, Gordon EK, Weingartner H, Kopin IJ. Catecholamine metabolism during clonidine withdrawal. Psychopharmacology. 84: 58-63. PMID 6436892 DOI: 10.1007/Bf00432025 |
0.319 |
|
| 1984 |
Newman RP, Weingartner H, Smallberg SA, Calne DB. Effortful and automatic memory: effects of dopamine. Neurology. 34: 805-7. PMID 6374497 DOI: 10.1212/Wnl.34.6.805 |
0.455 |
|
| 1984 |
Strupp BJ, Weingartner H. Vasopressin and cognition: An analysis and perspective Drug Development Research. 4: 501-516. DOI: 10.1002/Ddr.430040506 |
0.403 |
|
| 1983 |
Weingartner H, Grafman J, Boutelle W, Kaye W, Martin PR. Forms of memory failure. Science (New York, N.Y.). 221: 380-2. PMID 6867715 DOI: 10.1126/Science.6867715 |
0.429 |
|
| 1983 |
Silberman EK, Weingartner H, Post RM. Thinking disorder in depression. Archives of General Psychiatry. 40: 775-80. PMID 6860078 DOI: 10.1001/ARCHPSYC.1983.01790060073009 |
0.363 |
|
| 1983 |
Silberman EK, Weingartner H, Laraia M, Byrnes S, Post RM. Processing of emotional properties of stimuli by depressed and normal subjects. The Journal of Nervous and Mental Disease. 171: 10-4. PMID 6848642 DOI: 10.1097/00005053-198301000-00003 |
0.348 |
|
| 1983 |
Strupp B, Weingartner H, Goodwin FK, Gold PW. Neurohypophyseal hormones and cognition. Pharmacology & Therapeutics. 23: 267-79. PMID 6366828 DOI: 10.1016/0163-7258(83)90016-5 |
0.325 |
|
| 1983 |
Cohen RM, Cohen MR, Weingartner H, Pickar D, Murphy DL. High-dose naloxone affects task performance in normal subjects. Psychiatry Research. 8: 127-36. PMID 6304800 DOI: 10.1016/0165-1781(83)90100-2 |
0.396 |
|
| 1983 |
Cohen MR, Cohen RM, Pickar D, Weingartner H, Murphy DL. High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responses. Archives of General Psychiatry. 40: 613-9. PMID 6303264 DOI: 10.1001/Archpsyc.1983.04390010023003 |
0.33 |
|
| 1983 |
Linnoila M, Johnson J, Dubyoski T, Ross R, Buchsbaum M, Potter WZ, Weingartner H. Effects of amitriptyline, desipramine and zimeldine, alone and in combination with ethanol, on information processing and memory in healthy volunteers. Acta Psychiatrica Scandinavica. Supplementum. 308: 175-81. PMID 6230891 DOI: 10.1111/J.1600-0447.1983.Tb11121.X |
0.4 |
|
| 1983 |
Weingartner H, Buchsbaum MS, Linnoila M. Zimelidine effects on memory impairments produced by ethanol. Life Sciences. 33: 2159-63. PMID 6227781 DOI: 10.1016/0024-3205(83)90286-2 |
0.357 |
|
| 1983 |
Weingartner H, Rudorfer MV, Buchsbaum MS, Linnoila M. Effects of serotonin on memory impairments produced by ethanol. Science (New York, N.Y.). 221: 472-4. PMID 6223371 DOI: 10.1126/Science.6223371 |
0.4 |
|
| 1982 |
Cohen RM, Weingartner H, Smallberg SA, Pickar D, Murphy DL. Effort and cognition in depression. Archives of General Psychiatry. 39: 593-7. PMID 7092490 DOI: 10.1001/Archpsyc.1982.04290050061012 |
0.355 |
|
| 1982 |
Weingartner H, Langer D, Grice J, Rapoport JL. Acquisition and retrieval of information in amphetamine-treated hyperactive children. Psychiatry Research. 6: 21-9. PMID 6949168 DOI: 10.1016/0165-1781(82)90034-8 |
0.375 |
|
| 1981 |
Weingartner H, Cohen RM, Murphy DL, Martello J, Gerdt C. Cognitive processes in depression. Archives of General Psychiatry. 38: 42-7. PMID 7458568 DOI: 10.1001/Archpsyc.1981.01780260044004 |
0.325 |
|
| 1981 |
Weingartner H, Gold P, Ballenger JC, Smallberg SA, Summers R, Rubinow DR, Post RM, Goodwin FK. Effects of vasopressin on human memory functions. Science (New York, N.Y.). 211: 601-3. PMID 7455701 DOI: 10.1126/science.7455701 |
0.446 |
|
| 1981 |
Rapoport JL, Jensvold M, Elkins R, Buchsbaum MS, Weingartner H, Ludlow C, Zahn TP, Berg CJ, Neims AH. Behavioral and cognitive effects of caffeine in boys and adult males. The Journal of Nervous and Mental Disease. 169: 726-32. PMID 7299385 DOI: 10.1097/00005053-198111000-00007 |
0.344 |
|
| 1981 |
Weingartner H, Kaye W, Smallberg SA, Ebert MH, Gillin JC, Sitaram N. Memory failures in progressive idiopathic dementia. Journal of Abnormal Psychology. 90: 187-96. PMID 7288013 DOI: 10.1037/0021-843X.90.3.187 |
0.356 |
|
| 1981 |
Weingartner H, Kaye W, Gold P, Smallberg S, Peterson R, Gillin JC, Ebert M. Vasopressin treatment of cognitive dysfunction in progressive dementia. Life Sciences. 29: 2721-6. PMID 7035781 DOI: 10.1016/0024-3205(81)90531-2 |
0.441 |
|
| 1981 |
Parker ES, Morihisa JM, Wyatt RJ, Schwartz BL, Weingartner H, Stillman RC. The alcohol facilitation effect on memory: a dose-response study. Psychopharmacology. 74: 88-92. PMID 6791212 DOI: 10.1007/Bf00431763 |
0.336 |
|
| 1981 |
Caine ED, Weingartner H, Ludlow CL, Cudahy EA, Wehry S. Qualitative analysis of scopolamine-induced amnesia. Psychopharmacology. 74: 74-80. PMID 6791209 DOI: 10.1007/BF00431761 |
0.429 |
|
| 1980 |
Rapoport JL, Buchsbaum MS, Weingartner H, Zahn TP, Ludlow C, Mikkelsen EJ. Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Archives of General Psychiatry. 37: 933-43. PMID 7406657 DOI: 10.1001/archpsyc.1980.01780210091010 |
0.31 |
|
| 1980 |
Weingartner H, Rapoport JL, Buchsbaum MS, Bunney WE, Ebert MH, Mikkelsen EJ, Caine ED. Cognitive processes in normal and hyperactive children and their response to amphetamine treatment. Journal of Abnormal Psychology. 89: 25-37. PMID 7365116 DOI: 10.1037//0021-843X.89.1.25 |
0.305 |
|
| 1980 |
Parker ES, Birnbaum IM, Weingartner H, Hartley JT, Stillman RC, Wyatt RJ. Retrograde enhancement of human memory with alcohol. Psychopharmacology. 69: 219-22. PMID 6256791 DOI: 10.1007/BF00427653 |
0.376 |
|
| 1979 |
Weingartner H, Caine ED, Ebert MH. Imagery, encoding, and retrieval of information from memory: some specific encoding--retrieval changes in Huntington's disease. Journal of Abnormal Psychology. 88: 52-8. PMID 154532 DOI: 10.1037//0021-843X.88.1.52 |
0.353 |
|
| 1979 |
Reus VI, Targum SD, Weingartner H, Post RM. Effect of lithium carbonate on memory processes of bipolar affectively ill patients. Psychopharmacology. 63: 39-42. PMID 112620 DOI: 10.1007/BF00426919 |
0.371 |
|
| 1979 |
Gold PW, Weingartner H, Ballenger JC, Goodwin FK, Post RM. Effects of 1-desamo-8-D-arginine vasopressin on behaviour and cognition in primary affective disorder. Lancet. 2: 992-4. PMID 91778 DOI: 10.1016/S0140-6736(79)92563-7 |
0.39 |
|
| 1979 |
Reus VI, Weingartner H, Post RM. Clinical implications of state-dependent learning. The American Journal of Psychiatry. 136: 927-31. PMID 36764 DOI: 10.1176/AJP.136.7.927 |
0.319 |
|
| 1979 |
Weingartner H, Sitaram N, Gillin JC. The role of the cholinergic nervous system in memory consolidation Bulletin of the Psychonomic Society. 13: 9-11. DOI: 10.3758/Bf03334997 |
0.364 |
|
| 1978 |
Sitaram N, Weingartner H, Caine ED, Gillin JC. Choline: Selective enhancement of serial learning and encoding of low imagery words in man. Life Sciences. 22: 1555-60. PMID 672413 DOI: 10.1016/0024-3205(78)90011-5 |
0.354 |
|
| 1978 |
Sitaram N, Weingartner H, Gillin JC. Human serial learning: enhancement with arecholine and choline impairment with scopolamine. Science (New York, N.Y.). 201: 274-6. PMID 351808 DOI: 10.1126/SCIENCE.351808 |
0.355 |
|
| 1978 |
Rapoport JL, Buchsbaum MS, Zahn TP, Weingartner H, Ludlow C, Mikkelsen EJ. Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys. Science (New York, N.Y.). 199: 560-3. PMID 341313 DOI: 10.1126/Science.341313 |
0.336 |
|
| 1978 |
Caine ED, Hunt RD, Weingartner H, Ebert MH. Huntington's dementia. Clinical and neuropsychological features. Archives of General Psychiatry. 35: 377-84. PMID 153122 DOI: 10.1001/Archpsyc.1978.01770270127013 |
0.409 |
|
| 1977 |
Weingartner H, Miller H, Murphy DL. Mood-state-dependent retrieval of verbal associations. Journal of Abnormal Psychology. 86: 276-84. PMID 874186 DOI: 10.1037//0021-843X.86.3.276 |
0.406 |
|
| 1977 |
Caine ED, Ebert MH, Weingartner H. An outline for the analysis of dementia. The memory disorder of Huntingtons disease. Neurology. 27: 1087-92. PMID 144872 DOI: 10.1212/Wnl.27.11.1087 |
0.429 |
|
| 1976 |
Weingartner H, Adefris W, Eich JE, Murphy DL. Encoding-imagery specificity in alcohol state-dependent learning. Journal of Experimental Psychology. Human Learning and Memory. 2: 83-7. PMID 1249533 DOI: 10.1037/0278-7393.2.1.83 |
0.356 |
|
| 1975 |
Eich JE, Weingartner H, Stillman RC, Gillin JC. State-dependent accessibility of retrieval cues in the retention of a categorized list Journal of Verbal Learning and Verbal Behavior. 14: 408-417. DOI: 10.1016/S0022-5371(75)80020-X |
0.368 |
|
| 1974 |
Galanter M, Stillman R, Wyatt RJ, Vaughan TB, Weingartner H, Nurnberg FL. Marihuana and social behavior; a controlled study. Archives of General Psychiatry. 30: 518-21. PMID 4815558 DOI: 10.1001/Archpsyc.1974.01760100082013 |
0.315 |
|
| 1973 |
Henry GM, Weingartner H, Murphy DL. Influence of affective states and psychoactive drugs on verbal learning and memory. The American Journal of Psychiatry. 130: 966-71. PMID 4727774 DOI: 10.1176/Ajp.130.9.966 |
0.363 |
|
| 1973 |
Galanter M, Weingartner H, Vaughan TB, Roth WT, Wyatt RJ. 9 -Transtetrahydrocannabinol and natural marihuana. A controlled comparison. Archives of General Psychiatry. 28: 278-81. PMID 4684294 DOI: 10.1001/Archpsyc.1973.01750320106016 |
0.378 |
|
| 1971 |
Henry GM, Weingartner H, Murphy DL. Idiosyncratic patterns of learning and word association during mania. The American Journal of Psychiatry. 128: 564-74. PMID 5114371 DOI: 10.1176/Ajp.128.5.564 |
0.3 |
|
| 1971 |
Snyder SH, Weingartner H, Faillace LA. DOET (2,5-dimethoxy-4-ethylamphetamine), a new psychotropic drug. Effects of varying doses in man. Archives of General Psychiatry. 24: 50-5. PMID 4923215 DOI: 10.1001/archpsyc.1971.01750070052006 |
0.303 |
|
| 1970 |
Weingartner H, Snyder SH, Faillace LA, Markley H. Altered free associations: Some cognitive effects of DOET (2, 5-dimethoxy-4-ethylamphetamine) Behavioral Science. 15: 297-303. DOI: 10.1002/bs.3830150402 |
0.341 |
|
| 1968 |
SNYDER SH, FAILLACE LA, WEINGARTNER H. DOM (STP), a New Hallucinogenic Drug, and DOET: Effects in Normal Subjects American Journal of Psychiatry. 125: 357-364. DOI: 10.1176/ajp.125.3.357 |
0.37 |
|
| Show low-probability matches. |